CD8A and neoplasm: Inhibiting EZH2 using DZNep or EPZ can turn the tumor from cold to hot by activating the dsRNA/STING/IFN axis or downregulating the expression of protumor inflammatory cytokine G-CSF, resulting in upregulation of activated CD8+ T cells and downregulation of immunosuppressive neutrophils.